×
About 6,509 results

ALLMedicine Diabetic Ketoacidosis Center

Research & Reviews  2,357 results

Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA.
https://doi.org/10.1007/5584_2020_545
Advances in Experimental Medicine and Biology; Muneer M, Akbar I

Jun 2nd, 2020 - Emergency admissions due to acute metabolic crisis in patients with diabetes remain some of the most common and challenging conditions. DKA (Diabetic Ketoacidosis), HHS (Hyperglycaemic Hyperosmolar State) and recently focused EDKA (Euglycaemic Dia...

Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transpo...
https://doi.org/10.12659/AJCR.921536
The American Journal of Case Reports; Kasbawala K, Stamatiades GA et. al.

Jun 1st, 2020 - BACKGROUND Sodium glucose co-transporter 2 (SGLT2) inhibitors have become an appealing treatment for diabetes due to their favorable cardiac and renal outcomes. However, reports continue to emerge describing potentially life-threatening adverse ev...

Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diab...
https://doi.org/10.1097/MD.0000000000020228
Medicine Lee IH, Ahn DJ

Jun 1st, 2020 - Rare cases of euglycemic diabetic ketoacidosis (eu-DKA) have been reported after the administration of sodium-glucose cotransporter-2 (SGLT-2) inhibitors. No reports have described eu-DKA complicated by hypernatremia due to SGLT-2 inhibitors. A 76...

Etiologies, Trends and Predictors of 30-Day Pediatric Readmissions after Hospitalizatio...
https://doi.org/10.1111/pedi.13059
Pediatric Diabetes; Bhatt P, Dave M et. al.

May 28th, 2020 - To determine the causes, predictors, and trends of 30-day readmissions following hospitalizations for pediatric diabetic ketoacidosis (DKA) in the United States (US) from 2010-2014. We used International Classification of Diseases, ninth revision,...

Children with onset-ketoacidosis are admitted to the nearest hospital available, regard...
https://doi.org/10.1515/jpem-2020-0038
Journal of Pediatric Endocrinology & Metabolism : JPEM; Nagl K, Rosenbauer J et. al.

May 24th, 2020 - Background To investigate longitudinal trends of admissions with diabetic ketoacidosis (DKA) in new-onset type 1 diabetes (T1D) and subsequent duration of hospitalization in association with structural health care properties, such as size of treat...

see more →

Guidelines  7 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors
http://care.diabetesjournals.org/content/42/6/1147
Diabetes Care; Danne,T.,et al

May 31st, 2019 - Sodium–glucose cotransporter (SGLT) inhibitors are new oral antidiabetes medications shown to effectively reduce glycated hemoglobin (A1C) and glycemic variability, blood pressure, and body weight without intrinsic properties to cause hypoglycemia...

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycem...
https://cdn.ymaws.com/www.ispad.org/resource/resmgr/consensus_guidelines_2018_/11.diabetic_ketoacidosis_and.pdf

Apr 10th, 2018 - The biochemical criteria for the diagnosis of diabetic ketoacidosis (DKA) are: Hyperglycemia (blood glucose >11 mmol/L [≈200 mg/dL]) Venous pH <7. 3 or serum bicarbonate <15 mmol/L Ketonemia (blood ß-hydroxybuyrate ≥3 mmol/L) or moderate or large k.

Management of hyperosmolar hyperglycaemic state in adults with diabetes.
https://doi.org/10.1111/dme.12757
Diabetic Medicine : a Journal of the British Diabetic Association; Scott AR, et. al.

May 19th, 2015 - Hyperglycaemic hyperosmolar state (HHS) is a medical emergency, which differs from diabetic ketoacidosis (DKA) and requires a different approach. The present article summarizes the recent guidance on HHS that has been produced by the Joint British...

ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglyce...
https://doi.org/10.1111/pedi.12165
Pediatric Diabetes; Wolfsdorf JI, Allgrove J et. al.

Jul 21st, 2014 - ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state.|2014|Wolfsdorf JI,Allgrove J,Craig ME,Edge J,Glaser N,|trends,adverse effects,blood,complications,drug therapy,therapy,blood,complicatio...

see more →

Drugs  635 results see all →

Clinicaltrials.gov  3,207 results

Glimepiride - glimepiride tablet-Preferred Pharmaceuticals Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc5f6f59-881b-4bf9-9ec1-2f804cbdb1fc

Jun 3rd, 2020 - Glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies ( 14.1)]. Limitations of Use Glimepiride tablets should not be used for the treatment of...

Acute Metabolic Emergencies in Diabetes: DKA, HHS and EDKA.
https://doi.org/10.1007/5584_2020_545
Advances in Experimental Medicine and Biology; Muneer M, Akbar I

Jun 2nd, 2020 - Emergency admissions due to acute metabolic crisis in patients with diabetes remain some of the most common and challenging conditions. DKA (Diabetic Ketoacidosis), HHS (Hyperglycaemic Hyperosmolar State) and recently focused EDKA (Euglycaemic Dia...

Glipizide er - glipizide tablet, film coated, extended release-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5edf2f6-0956-403e-9608-e5f3b56b085b

Jun 2nd, 2020 - Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets are a sulfonylurea indicated as an adjunct to diet and exer...

Glipizide er - glipizide tablet, film coated, extended release-PD-Rx Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42308dd9-57c2-4416-a394-681f6733f566

Jun 2nd, 2020 - Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablets are a sulfonylurea indicated as an adjunct to diet and exer...

Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transpo...
https://doi.org/10.12659/AJCR.921536
The American Journal of Case Reports; Kasbawala K, Stamatiades GA et. al.

Jun 1st, 2020 - BACKGROUND Sodium glucose co-transporter 2 (SGLT2) inhibitors have become an appealing treatment for diabetes due to their favorable cardiac and renal outcomes. However, reports continue to emerge describing potentially life-threatening adverse ev...

see more →

News  299 results

Call for More Transparency in Gray Area of Post-Approval Drug Studies
https://www.medscape.com/viewarticle/930045

May 5th, 2020 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes "have received several serious safety warnings since approval, but the number, timeliness, and strength of these safety communications have differed between Ame...

More Guidance on Inpatient Management of Blood Glucose in COVID-19
https://www.medscape.com/viewarticle/929957

May 4th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. New guidance is available for managing inpatient hyperglycemia and diabetic ketoacidosis (DKA) in COVID-19 patients with diabetes using subcutane...

New Study of Diabetes Drug for COVID-19 Raises Eyebrows
https://www.medscape.com/viewarticle/929716

Apr 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A just-launched study of the type 2 diabetes agent dapagliflozin (Farxiga, AstraZeneca) in patients with mild-moderate COVID-19 is raising eyebrow...

Be Vigilant for Signs of Diabetes During COVID-19 Lockdown
https://www.medscape.com/viewarticle/929243

Apr 22nd, 2020 - As concerns about coronavirus deter people from seeking hospital care, endocrinologists and a leading UK charity are calling for general practitioners (GPs) and the public to be aware of the signs and symptoms of type 1 diabetes. Diabetes UK say t...

Checklist to Manage Hyperglycemia, DKA in Severe COVID-19
https://www.medscape.com/viewarticle/929092

Apr 20th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. With evidence mounting that hyperglycemia and diabetic ketoacidosis (DKA) are contributing to morbidity and mortality in COVID-19 — including amon...

see more →

Patient Education  4 results see all →